LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

LifeMD, Inc.NASDAQ: LFMD

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization declines year over year

Q1 FY2026 depreciation & amortization of $2M fell 24.9% year over year, ahead of the -127.4% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 19.7% from the prior quarter. Over 3 fiscal years it compounded at -55.7% a year.

Context

  • Depreciation & amortization amounted to 0.2% of revenue in FY2025, down 4.3 pp from a year earlier.
  • Depreciation & amortization increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -24.9% holds above the trailing-twelve-month pace of -127.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2M+19.7% QoQ
Last fiscal yearDec 2025
$328.37K-96.5% YoY
LTMMar 2026
-$2.76M-127.4% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-24.9%——
1 year-96.5%——
3-year CAGR-55.7%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
328.37K USD
Year-over-year change
-96.5%
4-year CAGR
-21.6%

Depreciation & Amortization vs competitors

How LFMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -127.4% is the lowest of 10, against a peer median of +15.6%.
  • Depreciation & amortization amounts to 1.3% of revenue for LFMD, versus a peer median of 3.6%.
LFMD Competitors
Depreciation & Amortization for LFMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TBRGTruBridge, Inc.LTM Mar 2026$43.33M USD+48.8%-17.1%12.5%
SMTISanara MedTech Inc.LTM Mar 2026$28.02M USD+456.0%+129.2%26.1%
HITIHigh Tide Inc.LTM Apr 2026CA$20.61M CAD-9.5%-6.9%3.1%
TKNOAlpha Teknova, Inc.LTM Mar 2026$6.34M USD-2.8%+26.1%15.2%
MASS908 Devices Inc.LTM Mar 2026$4.31M USD-7.1%+33.4%7.5%
LFMDLifeMD, Inc.LTM Mar 2026$2.76M USD-127.4%-55.7%1.3%
CERSCerus CorporationLTM Mar 2026$2M USD+30.3%-14.7%0.9%
SENSSenseonics Holdings, Inc.LTM Mar 2026$1.48M USD+102.1%-54.8%3.6%
CVRXCVRx, Inc.LTM Mar 2026$777K USD+15.6%+22.4%1.3%
SGHTSight Sciences, Inc.LTM Mar 2026$690K USD+3.1%-11.8%0.9%
Peer median (excluding LFMD) —+15.6%-6.9%3.6%

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(61.32M)(45.02M)(20.6M)(18.73M)15.62M
Depreciation & Amortization868.76K3.77M6.6M9.49M328.37K
Deferred Income Tax0354K000
Stock-Based Compensation12.07M13.73M12.49M12.23M10.5M
Change in Working Capital9.13M(1.55M)4.91M12.65M(7.85M)
Accounts Receivables17.7K(2.19M)(2.44M)(2.94M)1.15M
Inventory(409.82K)(2.18M)764.33K675.67K303.24K
Accounts Payables(893.96K)1.25M978.06K4.92M3.24M
Other Working Capital10.42M1.58M5.61M9.99M(12.55M)
Other Non-Cash Items6.17M5.78M5.42M1.87M(10.31M)
Operating Cash Flow(33.09M)(22.94M)8.82M17.51M8.28M
Capital Expenditures(3.4M)(12.89M)(8.73M)(11.54M)(9.52M)
Acquisitions (Net)0(1.01M)000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.15M)(12.53M)(8.53M)(10.05M)8.78M
Investing Cash Flow(3.4M)(13.91M)(8.73M)(11.54M)6.91M
Debt Repayment(530.82K)2.74M16.67M(327.6K)(18.72M)
Common Stock Issued13.99M016.2M09.19M
Common Stock Repurchased00000
Dividends Paid(871.48K)(3.11M)(3.11M)(3.11M)(3.11M)
Other Financing Activities707.36K(159.2K)(667.63K)(684.83K)(773.66K)
Financing Cash Flow68.64M(528.2K)29.1M(4.12M)(13.41M)
Effect of Forex Changes00000
Net Change in Cash32.15M(37.37M)29.19M1.86M1.78M
Free Cash Flow(36.49M)(35.83M)86.95K5.98M(1.24M)

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.